The skin is the largest organ of the body, and its cholesterol content has been directly associated with an increased carotid intima-media thickness in individuals without diagnosed cardiovascular disease, suggesting that measuring skin cholesterol content may be useful when attempting to identify individuals with subclinical asymptomatic atherosclerosis (9-11). Importantly, since deposition of cholesterol in skin xanthomas and in early atherosclerotic lesions has been suggested to share clearance from the skin and the arterial wall and, accordingly, enables RCT from these sites (13, 14).
6 site, weighted, and chopped up with scissors. The finely cut pieces were placed in 500 µl of distilled water in Eppendorf tubes and then subjected to 5 freeze-thaw cycles (liquid nitrogen-warm tap water).
TCA was then added to the tubes (final concentration 5%) after which they were thoroughly vortexed, incubated at +4°C for 30 min, and finally centrifuged at 10,000 g for 10 min. The clear supernatant was collected, the histamine content was determined fluorometrically (17), and the results were expressed as ng of histamine per area and per weight of skin.
Measurement of mast cell activation in skin
To induce degranulation of mast cells in the skin, 48/80 (2.5 mg/kg) was s.c. injected to mice. Mast cells were defined to be activated when extracellular granules were found in the immediate vicinity of the cells. For quantification of the number of activated mast cells, a piece of skin was cut from the treated skin sites and submerged in the tissue section medium Tissue-Tek O.C.T. (Sakura Finetek Europe). The skin samples were then rapidly frozen in liquid nitrogen and stored at -80⁰C to be further sectioned into 5 µm slices. The slices were stained in 0.1% Toluidine Blue and the number of activated mast cells was determined microscopically at 20x and expressed as % of the total number of mast cells, as described previously (18).
Stimulation of the vascular permeability of mice
The targeted site of skin for the multiple s.c. injections was confined to a skin area of a diameter of about 1 cm in the rostral back between the scapulae. Mice received s.c. injections of either histamine (250 µg/kg), serotonin (500 µg/kg), or bradykinin (500 µg/kg) in 100 l of saline, or vehicle alone as control. To further stimulate vascular permeability, the same dose of each respective compound was administered after 24 h of the initial dose. To block the H1 receptor (H1R) or the H2 receptor (H2R), or both, mice were i.p. injected with either pyrilamine (20 mg/kg), ranitidine (20 mg/kg), or with both histamine receptor antagonists, respectively, 1 h prior to histamine injection. Each experiment with the vasoactive compounds was repeated at least 2 times and the number of mice ranged from 10 to 15 per treatment, as indicated in the figure legends. dpm/mouse). Minimal volume of blood (ranging from 10 to 50 l) was drawn from the saphenous vein at 2 min, 30 min, 60 min, 3 h, 24 h, and 48 h. Plasma decay curves for the tracer were normalized to the serum radioactivity determined at the 2-min time point after injection of the radioactive tracer.
Mice were euthanized at 1 h, 24 h, and 48 h and samples of skin were dissected from the site of the s.c. injection. Tissues were rinsed with saline, finely chopped, and incubated overnight in 1 ml of 2N KOH at 37 o C. Radioactivity in serum and tissue extracts was measured by liquid scintillation counting (LSC).
Evaluation of macrophage-RCT (m-RCT) from skin-to-feces
We determined the in vivo m-RCT rate from skin-to-feces within a 48 h-period, as previously described (20) . In brief,  3 Hcholesterol-labeled J774 mouse macrophages (3-5 x10 6 cells; 2-5 x10 6 dpm per mouse) were s.c. injected into the rostral back area of mice, and immediately thereafter the various vasoactive compounds were injected into an adjacent skin site. To further stimulate vascular permeability, the dose of each vasoactive compound was administered 2 times within a 48 h-period, as described above. After the treatments, mice were maintained for 48 h in individual mesh bottom cages to quantitatively collect the fecal material. Gene expression of cholesterol efflux transporters in cultured J774 macrophages and determination of macrophage cholesterol efflux to mouse serum in vitro J774 cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin (BioWhittaker, Verviers, Belgium), seeded in 12-well plates at 5 x10 5 cells/well, and grown for 3 days. To mimic the in vivo flow and ensuing dilution and predicted decline in concentration of the s.c. injected compounds (histamine, serotonin, bradykinin) occurring in the interstitial fluid of the skin to which the labeled macrophages were exposed, the J774 cells were incubated with decreasing concentrations of each compound for various intervals of time, up to 3 h. Accordingly, the initial concentration of each compound in the incubation medium was the same as that injected to the mice; after 5 min of incubation the compound concentration was progressively reduced within intervals of 10 min to achieve up to a 100-fold reduction at 30 min of incubation. After such 30-min preconditioning period the incubation was prolonged until 3 h at this low concentration.
Macrophages incubated in only medium (non-conditioned cells) acted as controls. The preconditioned cells were then collected for quantitative RT-PCR analysis. Total RNA was isolated using RNeasy concentration and cholesterol efflux was determined during a 3-h incubation period. Efflux from nonconditioned macrophages to mouse serum in the absence of vasoactive compounds acted as the reference. Fractional cholesterol efflux (%) was calculated as dpm medium /(dpm cells + dpm medium ) x 100, as described before (20) . Efflux values in the absence of serum were subtracted from those in the presence of serum.
Other analyses
Total cholesterol, HDL-cholesterol, and triglyceride concentrations in mouse serum were measured enzymatically with commercial kits (Roche Diagnostics, Basel, Switzerland).
Statistical analysis
GraphPad Prism 4.0 software (GraphPad, San Diego, CA) was used to perform all statistical analyses. To test whether the histamine-mediated increase of vascular permeability in the skin was capable of modifying the RCT rate from macrophages located in the subcutaneous layer of the skin, significantly increased the content of radiolabeled cholesterol in serum and HDL, and also tended to increase it in the liver ( Figures 1A and 1B) . More importantly, the quantity of macrophage-derived
]cholesterol excreted into feces during the 48 h period was 2-fold higher in these mice in which the immediate vasoactive histamine stimulus was repeated at 24 h ( Figure 1C) . We further evaluated whether the effect of histamine on m-RCT involved the H1R and/or H2R, which we have been shown to stimulate the transendothelial transport of LDL from plasma to skin of rats in vivo (15) . For this purpose, mice received 1 h before the histamine dose an i.p. injection of either pyrilamine or ranitidine to antagonize H1R and H2R, respectively, and the fecal recovery of the macrophagederived 3 H-radioactivity was measured. As shown in Figure 2 , the stimulatory effect of histamine on the m-RCT from skin-to-feces was significantly reduced when the H1R antagonist was administered, and only slightly reduced when the H2R antagonist was administered. When administered together, the 2 antagonists exhibited a stronger effect, which supported the notion that the H2 antagonist had a small additive effect when combined with the H1 antagonist. Yet, no statistical difference was found between the values obtained when blocking only H1R or blocking both H1R and HR2. Overall these results indicated that the histamine-dependent effect on m-RCT was mainly mediated by H1R.
Histamine increases influx of HDL to skin
To get insight into the mechanism by which histamine induced m-RCT from the treated skin, we evaluated the capability of the locally injected histamine to induce the influx of [ 
Serotonin and bradykinin stimulate HDL uptake by skin and promote RCT from skin macrophages to feces
To further test the hypothesis that the histamine-induced increase in the influx of HDL into the skin was due to increased vascular permeability, we repeated the above experiment using 2 other natural vasoactive compounds. We selected serotonin and bradykinin, which, like histamine, are endogenous inflammatory mediators which have been demonstrated to also rapidly increase vascular permeability in rodents (15, 21) . Thus, mice received s.c. injections of either serotonin (500 µg/kg), bradykinin (500 µg/kg), or vehicle, and the influx of i.v. injected .03) which may partially explain its less marked effect in blocking the stimulatory effect of histamine on m-RCT (see Figure 2) . Importantly, the efficiency of the preconditioned macrophages to efflux cholesterol was not affected when the cells were further incubated for 3 h in mouse serumcontaining medium ( Figure 5B) . Analysis of serum lipids in mice treated with histamine and histamine receptor antagonists indicated that administration of the various compounds did not affect circulating lipid levels, particularly HDL-cholesterol, indicating that the treatments had not modified the cholesterol efflux capacity of the serum (Table 1A) . Neither did serotonin influence serum lipids;
however, bradykinin treatment decreased triglyceride levels without having any effect on HDLcholesterol levels (Table 1B) . Altogether, these results provided strong supportive evidence for the claim that a local increase in the vascular permeability inducing enhanced entry of HDL particles into skin, rather than modification of the intrinsic efficiency of the macrophage cholesterol efflux pathways, was the driving mechanism promoting m-RCT in vivo when skin was treated with the vasoactive compounds.
Histamine administration to apoA-I-deficient mice increases m-RCT from skin-to-feces in the presence of exogenous HDL
Because the stimulatory effect of increasing vascular permeability on m-RCT depended on the increased passage of HDL particles to the skin site where the macrophage foam cells were present, it seemed very likely that under conditions of low serum HDL levels the effect of the vasoactive compounds on m-RCT would be reduced. We predicted that in this experimental setting a transient enrichment of serum with exogenous HDL would result in enhanced passage of HDL through the leaky endothelium to the skin site, thereby stimulating the m-RCT rate. We tested these predictions in apoA-I-KO mice, which present 2-fold lower levels of HDL-cholesterol relative to the wild-type mice (Table 1C ). The basic m-RCT protocol used in this work was applied with the exception that the mice received an i.v. injection of HDL isolated from wild-type mice immediately after the initial s.c.
injection of histamine. The single dose of HDL had only a short-lasting effect on the basal low HDL levels, and, accordingly, after 48 h the plasma lipids were not changed ( Table 1C) . Measurement of the transfer of macrophage-derived cholesterol to feces indicated that administration of merely histamine to apoA-I-KO mice resulted in a slight, non-significant increase of m-RCT (Figure 6 ), which may have been caused by the low residual levels of apoA-I-deficient HDL in the serum of these mice. Neither did i.v. administration of HDL alone, i.e. without histamine, produce any effect on m-RCT. However, when exogenous HDL was administered together with histamine, the m-RCT rate increased significantly. Altogether, these data showed that, on a low-HDL background, increase of circulating HDL levels and triggering of local vascular leakage were both required to enhance passage We speculated that if apoB-lipoproteins, instead of HDL, were the predominant class of lipoproteins in the mouse plasma, the beneficial effect on m-RCT of increasing the vascular permeability could be challenged. Thus, following our basic protocol we evaluated the effect of histamine on the rate of m-RCT from skin in the atherosclerosis-prone LDLr-KO mice, which exhibit normal HDL levels but 10-fold higher levels of non-HDL (apoB-lipoproteins) relative to the wild-type (Table 1D) . We found that, under such hypercholesterolemic background, histamine did not increase the transfer of macrophage-derived radioactivity to serum, liver, or feces (Figure 7) . However, the magnitude of the recovered macrophage-derived radioactivity reflected high transfer rates to serum, and particularly to the non-HDL fraction (Figure 7A) , which accounted ~80% of the total radioactivity in the serum of both vehicle-and histamine-treated mice. The high levels of the 3 H-tracer recovered in feces suggested that LDLr-KO mice might exhibit high m-RCT rates already under basal conditions, i.e.
4-fold higher total radioactivity in feces (0.45% of injected dose) relative to the wild-type mice (0.11% in Figure 1C , and 0.10% in Figures 4B and 4C) . The finding that histamine did not have any further effect on such apparently accelerated basal m-RCT rate in LDLr-KO mice rather suggested that histamine and hypercholesterolemia may have shared a common stimulatory mechanism, such as the vascular leakage, which has been, indeed, found to occur in hypercholesterolemic mice (22, 23). Importantly, this effect was sufficient to increase the rate of RCT originating in vivo from macrophages located within the treated skin area. Because none of the vasoactive compounds studied here affected the serum HDL levels or the rate of cholesterol efflux from the cultured J774 macrophages, the stimulation of m-RCT in vivo must have been due to increased entry of circulating HDL into the treated skin, rather than due to an increased cholesterol efflux potential of the cholesterol acceptors or donors per se. These findings support a novel independent role for the rate of the passage of plasma HDL to the interstitial fluids in regulating m-RCT rate from peripheral tissues and, accordingly, the cholesterol content of macrophages in these body compartments.
Endogenous histamine-released from activated mast cells increases m-RCT from skin
The passage of lipoproteins across the normal intact endothelium is a regulated process which occurs maily by transcellular routes (28) , while the ultrafiltration of circulating lipoproteins at sites of endothelial activation where vascular permeability is increased has been found to be a paracellular process which occurs at the site of gaps between the endothelial cells (29) . It has been established that inflammatory mediators such as histamine, bradykinin, serotonin, and other vasoactive compounds, upon binding to their receptors on endothelial cells, disrupt the organization of the interendothelial junctions, thus leading to opening of the endothelial barrier (30) . The size of the gaps can be considerable, e.g., it was reported that substance P may induce gaps in the interendothelial junctions of endothelial cells in vessels of the rat trachea that range from 100 to 400 nm and have a half-life of ~1.9 min (31). Histamine, a vasoactive compound primarily released by activated mast cells, and in small quantities also by other cells, such as the endothelial cells themselves, is the most studied compound in in vitro models of vascular permeability. Importantly, the increase of vascular permeability induced by histamine has resulted in immediate extravasation of LDL from plasma to skin in rats and hamsters (15, 32) . The rapid extravascular accumulation of LDL most likely results from the sieving of lipoproteins through water pores of ~22 nm in radius, up to the size of LDL (32).
Such transient increase in endothelial permeability induced by histamine may be prolonged by thrombin via a mechanism which involves modulation of the intracellular levels of calcium ions, as it was shown in human endothelial cell monolayers (33).
Because the permeability-enhancing effect of histamine is rapid and transitory, we administered 2 subsequent doses, which, by opening the endothelial gaps twice, facilitated the influx of sufficient amounts of circulating HDL into the skin and increased m-RCT rate over a 48-h period. Under these experimental conditions the stimulatory effect of histamine on m-RCT appeared to be mediated mainly by the H1 receptor, with the H2 receptor exerting a small additive effect. Consistent with our findings, activation of H1R, rather than H2R, has been found to enhance vascular permeability for endogenous LDL in cholesterol-fed apoE -/ -mice without altering the plasma lipoprotein levels (34). It has been also shown that histamine increases the passage of LDL through monolayers of human arterial endothelial cells, having its peak at 2 h but rapidly decreasing to the control level within 4-6 h, and, moreover, that this effect can be blocked by the H1R antagonist pyrilamine, rather than by the H2R antagonist cimetidine (35) . The requirement of 2 doses of histamine for the m-RCT response could also mean that the second dose of histamine had an additive effect which was qualitatively different from that achieved with the initial dose, e.g. on the lymph flow. Indeed, complex and even opposite effects of histamine on the lymphatic function have been reported. Thus, histamine appeared to stimulate the lymphatic vessel contractile activity (36) , to act as an endothelium-derived relaxing factor in mesenteric lymphatic vessels (37) , or to disrupt the integrity of the barrier function of lymphatic endothelial cells, thereby potentiating leakage of solutes from lymph back to the interstitial space (38) . Whether the second dose of histamine had also activated the lymphatic SR-BI transporter recently found to regulate the entry of HDL into the lymphatic vessels (14) remains unknown.
In the present studies we use wild-type mice fed a standard chow diet as our experimental model.
However, in contrast to mice which are HDL animals, in humans most of the cholesterol is transported in LDL and, moreover, severe hypercholesterolemia due to increased LDL levels is associated to accumulation of cholesterol in peripheral tissues, particularly in the intimal layer of arteries generating atherosclerotic lesions and also in the skin generating xanthomas (39) . In this context, it is of particular relevance that also genetic absence of apoA-I in humans results in the formation of skin xanthomas, so revealing a critical role of this apolipoprotein in the regulation of skin cholesterol balance (40) . Notably, the present results support the view that an increased passage of apoA-I-containing HDL to the interstitial fluid of the skin is capable of locally accelerating m-RCT from cholesterol-loaded cells and so potentially able to decrease the accumulation of cholesterol found in skin xanthomas. In an attempt to mimic the human hypercholesterolemic phenotype, we also evaluated the effect of increasing vascular permeability in the LDLr-KO mouse which exhibits high non-HDL/HDL ratio and is considered an animal model of familial hypercholesterolemia (FH) (41) .
Surprisingly, the basal rate of m-RCT already appeared to be increased in the untreated LDLr-KO mice relative to the untreated wild-type mice (compare the vehicle groups in Figure 7C and The present study is the first to link an increased endothelial permeability with increased rates of RCT from peripheral tissue macrophages. It was recently reported that the function of lymphatic vessels clearing HDL from skin remains dominant conduits for m-RCT also in tissues surrounding an implanted tumor in mice characterized by increased vascular permeability (13) . A more detailed characterization of the relative roles played by the vascular permeability and lymphatic drainage regulating coordinately the inward and outward flow of HDL on the RCT rate deserves further investigation. Finally, we envision that the proatherogenic effect of increased vascular permeability that is associated with increased influx of LDL (15) The influx of HDL to skin and decay curves for the tracer in plasma were evaluated up to 24 h in mice that received s.c. injections of serotonin (500 µg/kg), bradykinin (500 µg/kg), or vehicle alone immediately followed by i.v. injection of a labeled HDL preparation, as described in Figure 3 ..
Samples of skin were dissected from the site of s.c. injection at 1 h and 24 h, and blood samples analyzed for the decay curves (inset) were collected at similar time points as described in was assessed after the preconditioning incubation step of the cells in the presence of the vasoactive compounds at their final concentrations, as described above. Non-preconditioned macrophages incubated in the absence of vasoactive compounds and in the presence of serum alone acted as control. Fractional cholesterol efflux (%) was expressed as dpm medium /(dpm cells + dpm medium ) x 100 (B).
All data represent the mean ± SEM from 4 replicate wells. 
